Kate Moreau

Dr. Kate Moreau is an Analyst at RA Capital Management LLC.
Dr. Moreau's primary responsibility at RA Capital is to identify compelling assets to help facilitate new company creation or investments in emerging seed-stage companies.
Prior to this role, she was a Senior Associate on the Landscape Team within the TechAtlas division of RA Capital, where she mapped competitive landscapes in ophthalmology, lower GI, and gene therapy, and performed in-depth analyses of pharma pipelines.
She holds a BA in Molecular Biology and Biochemistry from Rutgers University and a PhD in Biochemistry from MIT.
Her doctoral research investigated the folding and aggregation of gamma-crystallins associated with cataract formation.